NCT02135549View on ClinicalTrials.gov

Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With Metformin

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

SugarDown

4 or 8 gram dose in tablet form, before meals, daily for one week

DRUG

Placebo Oral Tablet

Placebo comparator

Trial Locations (1)

11530

Accumed, Garden City

Sponsors
All Listed Sponsors
lead

Boston Therapeutics

INDUSTRY